Edition:
India

Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

89.66EUR
19 Jan 2018
Change (% chg)

€-0.46 (-0.51%)
Prev Close
€90.12
Open
€90.22
Day's High
€90.70
Day's Low
€89.50
Volume
675,971
Avg. Vol
562,216
52-wk High
€115.20
52-wk Low
€87.23

Chart for

About

Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company operates through four business segments: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnol... (more)

Overall

Beta: 1.01
Market Cap(Mil.): €12,352.97
Shares Outstanding(Mil.): 129.24
Dividend: 1.20
Yield (%): 1.26

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-Forty Seven Says Agreement With Merck KGAA To Conduct Clinical Trials For Patients With Ovarian Cancer

* FORTY SEVEN - AGREEMENT WITH MERCK KGAA TO CONDUCT PHASE 1B CLINICAL TRIAL COMBINING HU5F9-G4 WITH AVELUMAB IN PATIENTS WITH OVARIAN CANCER Source text for Eikon: Further company coverage:

11 Jan 2018

Nestle frontrunner for Merck KGaA's consumer health business: Bloomberg

ZURICH Nestle is the frontrunner to buy Merck KGaA's consumer health unit that could fetch as much as $5 billion, financial news service Bloomberg said on Wednesday, quoting unidentified sources familiar with the matter.

10 Jan 2018

Nestle frontrunner for Merck KGaA's consumer health business - Bloomberg

ZURICH, Jan 10 Nestle is the frontrunner to buy Merck KGaA's consumer health unit that could fetch as much as $5 billion, financial news service Bloomberg said on Wednesday, quoting unidentified sources familiar with the matter.

10 Jan 2018

BRIEF-Juniper Pharmaceuticals Announces ‍Extension Of Supply Agreement For Crinone

* JUNIPER PHARMACEUTICALS ANNOUNCES 4.5-YEAR EXTENSION THROUGH 2024 OF CRINONE® SUPPLY AGREEMENT WITH MERCK KGAA, DARMSTADT, GERMANY

08 Jan 2018

BRIEF-HTG Molecular Diagnostics Expands Its Collaboration With Merck

* HTG MOLECULAR DIAGNOSTICS EXPANDS ITS COLLABORATION WITH MERCK KGAA, DARMSTADT, GERMANY

27 Dec 2017

BRIEF-Merck And Bluebird Bio Sign Supply Agreement For Commercial Production Of Viral Vectors

* MERCK AND BLUEBIRD BIO SIGN SUPPLY AGREEMENT FOR COMMERCIAL PRODUCTION OF VIRAL VECTORS Source text - http://bit.ly/2DfAvDy Further company coverage: (Gdynia Newsroom)

20 Dec 2017

Germany's Merck in fresh bid to enter U.S. MS pill market

FRANKFURT Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales despite regulatory concerns about side effects having frustrated its ambitions almost seven years ago.

15 Dec 2017

UPDATE 2-Germany's Merck in fresh bid to enter U.S. MS pill market

* Unit head Garijo says targeting most severely affected patients

15 Dec 2017

Perrigo lines up bid for Merck's consumer health unit: sources

LONDON/FRANKFURT Generic drugmaker Perrigo has decided to enter the fray for Merck KGaA's consumer health unit, sources told Reuters, and is preparing an indicative offer for the $4.7 billion business ahead of a deadline on Friday.

15 Dec 2017

UPDATE 1-Perrigo lines up bid for Merck's consumer health unit -sources

* Perrigo to submit non-binding offer for Merck KGaA's OTC unit

15 Dec 2017

Earnings vs. Estimates